Of those, a subset of 32, which includes CCN1, has been previously shown by chromatin immunoprecipitation assay to be under the control of mechanosensitive YAP/TAZ in MDA‐MB‐231 breast cancer cells (Zanconato et al, 2015; Dataset EV1). Here, CCN1 is linked to breast carcinoma.